arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Streamex Corp.

STEX Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus
$0.76
Today
as of Jul 22, 16:54 ET
Last 30 days -21.66% Jun 12 → Jul 22
$0.71 $0.81 $0.92 $1.02 $1.12 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$1.16
High
$1.16
Low
$1.02
Volume
$1M
Avg Vol
$1M
Mkt Cap
$77M
P/E (TTM)
—
Beta
—
52w High
$14.11
52w Low
$0.70
Div Yield
—
Shares Out
$98M

Recent Press Releases & News last 60 days · 2 items

Jul 7 · 12:17 MT Newswires
Streamex Authorizes Buyback Plan for Up to 10 Million Shares
Jun 27 · 18:06 Simply Wall St.
Streamex (NasdaqCM:STEX) Stock Fair Value Falls As GLDY Rollout Concerns Temper Partnership Optimism

Overview

52-week range
$0.70
$14
0% of range
Avg surprise (last 2)
-965.0%
Avg reaction (last 2)
+8.6%
100% positive
Latest IV / EM
172%
EM ±39.4% · $1 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.58$-1.20$-0.81$-0.43$-0.04 Actual $-1.58Actual $-0.61Actual $-0.36Actual $-0.30Actual $-0.12Actual $-0.14Est $-0.05Actual $-0.74Est $-0.04Actual $-0.47Actual $-0.27 JunSepMarJunSepMar/2025Jun/2025SepMar/2026
Revenue vs Net Income Revenue Net income
$-47M$-35M$-23M$-12M$13,650 Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-0.27 — — -92.9% +8.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.47 — — — — financials
Fri Aug 15, 2025Jun/2025 $-0.74 $-0.04 -1,750% — — earnings
Mon May 19, 2025Mar/2025 $-0.14 $-0.05 -180.0% — +9.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.12 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.30 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.36 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.61 — — — — financials
Fri Jun 30, 2023Jun 2023 $-1.58 — — — — financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue———————$13,000
Cost of revenue————————
Gross profit————————
Operating income$-36M—$-6M$-20M$-3M—$-3M$-5M
Net income$-47M—$-16M$-20M$-3M—$-2M$-4M
EPS (diluted)$-0.27—$-0.47$-0.74$-0.14—$-0.12$-0.30

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$7M———————
Inventory————————
Total current assets$46M$72M$15M$3M$4M$344,000$848,000$2M
Total assets$173M$188M$131M$110M$4M$842,000$1M$3M
Long-term debt————————
Total liabilities$14M$54M$137M$113M$2M$2M$2M$3M
Total equity$159M$133M$-7M$-4M$3M$-2M$-405,000$-6,000

Implied volatility — last 90 days

143%510%878%1245%1613% Jun 08 — IV 170% · EM ±22.5%Jun 09 — IV 203% · EM ±25.4%Jun 10 — IV 230% · EM ±27.1%Jun 11 — IV 234% · EM ±25.9%Jun 15 — IV 261% · EM ±18.9%Jun 16 — IV 319% · EM ±18.9%Jun 17 — IV 760% · EM ±31.7%Jun 19 — IV 198% · EM ±43.7%Jun 22 — IV 153% · EM ±32.0%Jun 23 — IV 199% · EM ±40.7%Jun 24 — IV 172% · EM ±34.5%Jun 25 — IV 442% · EM ±86.7%Jun 26 — IV 200% · EM ±38.2%Jun 29 — IV 193% · EM ±34.3%Jun 30 — IV 188% · EM ±32.3%Jul 01 — IV 155% · EM ±25.9%Jul 02 — IV 143% · EM ±23.1%Jul 03 — IV 148% · EM ±23.2%Jul 06 — IV 177% · EM ±24.6%Jul 07 — IV 164% · EM ±21.6%Jul 08 — IV 163% · EM ±20.4%Jul 09 — IV 203% · EM ±23.9%Jul 10 — IV 173% · EM ±19.1%Jul 13 — IV 511% · EM ±42.7%Jul 14 — IV 585% · EM ±42.3%Jul 15 — IV 945% · EM ±55.8%Jul 16 — IV 1614% · EM ±67.4%Jul 20 — IV 204% · EM ±48.3%Jul 21 — IV 159% · EM ±37.0%Jul 22 — IV 172% · EM ±39.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in